Shentracon Chemicals Ltd

As of June 30, 2026, Shentracon Chemicals Ltd carries a market capitalization of 425.74M, placing it among publicly traded companies globally. Its enterprise value stands at 425.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Shentracon Chemicals Ltd has 4.05M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 409.36 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 425.74M versus a market cap of 425.74M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of the close on September 28, 2026.

Over the twelve months ended June 30, 2026, Shentracon Chemicals Ltd generated 1.04M in revenue and converted that into -3.96M in net income, yielding earnings per share of -0.93. EBITDA reached -5.66M, while operating income came in at -258,000.00.

Over the twelve months ended June 30, 2026, Shentracon Chemicals Ltd posted a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -24.81 and net profit margin of -380.87 provide insight into operational efficiency.